Hypercholesterolemia Interferes with Induction of MiR-125b-1-3p in Preconditioned Hearts

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2020 May 30

PMID 32466450

Citations 12

Authors

Marton R Szabo

Renata Gaspar

Marton Pipicz

Nora Zsindely

Petra Dioszegi

Marta Sarkozy

Laszlo Bodai

Tamas Csont

Affiliations

Soon will be listed here.

Abstract

Ischemic preconditioning (IPre) reduces ischemia/reperfusion (I/R) injury in the heart. The non-coding microRNA miR-125b-1-3p has been demonstrated to play a role in the mechanism of IPre. Hypercholesterolemia is known to attenuate the cardioprotective effect of preconditioning; nevertheless, the exact underlying mechanisms are not clear. Here we investigated, whether hypercholesterolemia influences the induction of miR-125b-1-3p by IPre. Male Wistar rats were fed with a rodent chow supplemented with 2% cholesterol and 0.25% sodium-cholate hydrate for 8 weeks to induce high blood cholesterol levels. The hearts of normo- and hypercholesterolemic animals were then isolated and perfused according to Langendorff, and were subjected to 35 min global ischemia and 120 min reperfusion with or without IPre (3 × 5 min I/R cycles applied before index ischemia). IPre significantly reduced infarct size in the hearts of normocholesterolemic rats; however, IPre was ineffective in the hearts of hypercholesterolemic animals. Similarly, miR-125b-1-3p was upregulated by IPre in hearts of normocholesterolemic rats, while in the hearts of hypercholesterolemic animals IPre failed to increase miR-125b-1-3p significantly. Phosphorylation of cardiac Akt, ERK, and STAT3 was not significantly different in any of the groups at the end of reperfusion. Based on these results we propose here that hypercholesterolemia attenuates the upregulation of miR-125b-1-3p by IPre, which seems to be associated with the loss of cardioprotection.

Citing Articles

Kynurenic acid protects against ischemia/reperfusion injury by modulating apoptosis in cardiomyocytes.

Gaspar R, Nogradi-Halmi D, Demjan V, Dioszegi P, Igaz N, Vincze A Apoptosis. 2024; 29(9-10):1483-1498.

PMID: 39153038 PMC: 11416393. DOI: 10.1007/s10495-024-02004-w.

The expression of MIR125B transcripts and bone phenotypes in Mir125b2-deficient mice.

Ogasawara T, Ito S, Ogashira S, Hoshino T, Sotomaru Y, Yoshiko Y PLoS One. 2024; 19(7):e0304074.

PMID: 38976685 PMC: 11230526. DOI: 10.1371/journal.pone.0304074.

Peripheral blood mononuclear cells expression of miR-200c, miR-125b, miR-27b, miR-203, and miR-155 in patients with significant or insignificant coronary artery stenosis.

Saadatian Z, Mansoori Y, Nariman-Saleh-Fam L, Daraei A, Zununi Vahed S, Navid S Sci Rep. 2023; 13(1):18438.

PMID: 37891322 PMC: 10611722. DOI: 10.1038/s41598-023-45146-8.

Altered MicroRNA Maturation in Ischemic Hearts: Implication of Hypoxia on XPO5 and DICER1 Dysregulation and RedoximiR State.

Perez-Carrillo L, Gimenez-Escamilla I, Garcia-Manzanares M, Trivino J, Feijoo-Bandin S, Aragon-Herrera A Antioxidants (Basel). 2023; 12(7).

PMID: 37507877 PMC: 10376795. DOI: 10.3390/antiox12071337.

Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning.

Ferdinandy P, Andreadou I, Baxter G, Botker H, Davidson S, Dobrev D Pharmacol Rev. 2023; 75(1):159-216.

PMID: 36753049 PMC: 9832381. DOI: 10.1124/pharmrev.121.000348.

References

Murry C, Jennings R, Reimer K . Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986; 74(5):1124-36. DOI: 10.1161/01.cir.74.5.1124. View

Timmis A, Townsend N, Gale C, Torbica A, Lettino M, Petersen S . European Society of Cardiology: Cardiovascular Disease Statistics 2019. Eur Heart J. 2019; 41(1):12-85. DOI: 10.1093/eurheartj/ehz859. View

Ferdinandy P, Csonka C, Csont T, Szilvassy Z, Dux L . Rapid pacing-induced preconditioning is recaptured by farnesol treatment in hearts of cholesterol-fed rats: role of polyprenyl derivatives and nitric oxide. Mol Cell Biochem. 1998; 186(1-2):27-34. View

Ferdinandy P, Szilvassy Z, Horvath L, Csont T, Csonka C, Nagy E . Loss of pacing-induced preconditioning in rat hearts: role of nitric oxide and cholesterol-enriched diet. J Mol Cell Cardiol. 1998; 29(12):3321-33. DOI: 10.1006/jmcc.1997.0557. View

Nagpal V, Rai R, Place A, Murphy S, Verma S, Ghosh A . MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis. Circulation. 2015; 133(3):291-301. PMC: 5446084. DOI: 10.1161/CIRCULATIONAHA.115.018174. View

Anders S, Huber W . Differential expression analysis for sequence count data. Genome Biol. 2010; 11(10):R106. PMC: 3218662. DOI: 10.1186/gb-2010-11-10-r106. View

Csont T, Bereczki E, Bencsik P, Fodor G, Gorbe A, Zvara A . Hypercholesterolemia increases myocardial oxidative and nitrosative stress thereby leading to cardiac dysfunction in apoB-100 transgenic mice. Cardiovasc Res. 2007; 76(1):100-9. DOI: 10.1016/j.cardiores.2007.06.006. View

Giricz Z, Lalu M, Csonka C, Bencsik P, Schulz R, Ferdinandy P . Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition. J Pharmacol Exp Ther. 2005; 316(1):154-61. DOI: 10.1124/jpet.105.091140. View

Xiao C, Wang K, Xu Y, Hu H, Zhang N, Wang Y . Transplanted Mesenchymal Stem Cells Reduce Autophagic Flux in Infarcted Hearts via the Exosomal Transfer of miR-125b. Circ Res. 2018; 123(5):564-578. DOI: 10.1161/CIRCRESAHA.118.312758. View

10.

Kocsis G, Sarkozy M, Bencsik P, Pipicz M, Varga Z, Paloczi J . Preconditioning protects the heart in a prolonged uremic condition. Am J Physiol Heart Circ Physiol. 2012; 303(10):H1229-36. DOI: 10.1152/ajpheart.00379.2012. View

11.

Heusch G, Musiolik J, Gedik N, Skyschally A . Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion. Circ Res. 2011; 109(11):1302-8. DOI: 10.1161/CIRCRESAHA.111.255604. View

12.

Pipicz M, Demjan V, Sarkozy M, Csont T . Effects of Cardiovascular Risk Factors on Cardiac STAT3. Int J Mol Sci. 2018; 19(11). PMC: 6274853. DOI: 10.3390/ijms19113572. View

13.

Ueda Y, Kitakaze M, Komamura K, Minamino T, Asanuma H, Sato H . Pravastatin restored the infarct size-limiting effect of ischemic preconditioning blunted by hypercholesterolemia in the rabbit model of myocardial infarction. J Am Coll Cardiol. 1999; 34(7):2120-5. DOI: 10.1016/s0735-1097(99)00440-4. View

14.

Csonka C, Kupai K, Kocsis G, Novak G, Fekete V, Bencsik P . Measurement of myocardial infarct size in preclinical studies. J Pharmacol Toxicol Methods. 2010; 61(2):163-70. DOI: 10.1016/j.vascn.2010.02.014. View

15.

Bellis A, Castaldo D, Trimarco V, Monti M, Chivasso P, Sadoshima J . Cross-talk between PKA and Akt protects endothelial cells from apoptosis in the late ischemic preconditioning. Arterioscler Thromb Vasc Biol. 2009; 29(8):1207-12. DOI: 10.1161/ATVBAHA.109.184135. View

16.

Sarkozy M, Gaspar R, Zvara A, Siska A, Kovari B, Szucs G . Chronic kidney disease induces left ventricular overexpression of the pro-hypertrophic microRNA-212. Sci Rep. 2019; 9(1):1302. PMC: 6362219. DOI: 10.1038/s41598-018-37690-5. View

17.

Heusch G . Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. Circ Res. 2015; 116(4):674-99. DOI: 10.1161/CIRCRESAHA.116.305348. View

18.

Friedlander M, Mackowiak S, Li N, Chen W, Rajewsky N . miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res. 2011; 40(1):37-52. PMC: 3245920. DOI: 10.1093/nar/gkr688. View

19.

Li Q, Qin M, Li T, Gu Z, Tan Q, Huang P . Rutin protects against pirarubicin-induced cardiotoxicity by adjusting microRNA-125b-1-3p-mediated JunD signaling pathway. Mol Cell Biochem. 2020; 466(1-2):139-148. DOI: 10.1007/s11010-020-03696-9. View

20.

Varga Z, Kupai K, Szucs G, Gaspar R, Paloczi J, Farago N . MicroRNA-25-dependent up-regulation of NADPH oxidase 4 (NOX4) mediates hypercholesterolemia-induced oxidative/nitrative stress and subsequent dysfunction in the heart. J Mol Cell Cardiol. 2013; 62:111-21. DOI: 10.1016/j.yjmcc.2013.05.009. View